Introduction * Understanding various genes and pathways underlying development of multicellular organisms should provide insights into the molecular basis of the highly regulated processes of cellular proliferation and differentiation. In turn, genetic aberrations in control of cell growth lead to a variety of developmental abnormalities and, most prominently, cancer (Aaronson, 1991) . To pursue identification of genes involved in these fundamental biological processes, the viable pygmy mutation (MacArthur, 1944) was investigated because it gives rise to mice of small stature owing to a disruption in overall growth and development of the mouse. An insertional transgenic mutant facilitated cloning of the locus (Xiang et al., 1990) , and subsequently it was shown that expression of the HMGI-C gene was abrogated in three pygmy alleles (Zhou et al., submitted).
HMGI-C belongs to the high mobility group (HMG) family of DNA-binding proteins that are abundant, heterogeneous, nonhistone components of chromatin (Grosschedl et al., 1994) . HMG proteins are divided into three distinct families, the HMG boxcontaining HMGl/HMG2, the active chromatin-associated HMGl4/HMG17, and the HMGI proteins (Grosschedl et al., 1994) . At present, the last family consists of two genes, HMGI(Y), which produces two proteins via alternative splicing (Friedmann et al., 1993) , and HMGI-C (Pate1 et al., 1994) . A prominent feature of HMGI proteins is the presence of DNA-binding domains that bind to the narrow minor groove of AT-rich DNA (Reeves and Nissen, 1990) and are therefore referred to as AT hooks. Recently, valuable insights have been gained into their mechanism and role in transcription (Thanos and Maniatis, 1992; Du et al., 1993) . They have no transcriptional activity per se (Wolffe, 1994) , but through protein-protein and protein-DNA interactions, they organize the framework of the nucleoprotein-DNA transcriptional complex. This is attained by their ability to change the conformation of DNA, and these proteins are therefore termed architectural factors (Wolffe, 1994) . In the wellstudied case of HMGI(Y) and the interferon p promoter, HMGI(Y) stimulates binding of NF-KB and ATF2 to appropriate sequences and alters the DNA structure that allows the two factors to interact with each other and presumably with the basal transcription machinery (Thanos and Maniatis, 1992; Du et al., 1993) .
A number of studies have revealed an association between increased expression levels of HMGI proteins and transformation (Giancotti et al., 1987 (Giancotti et al., ,1989 . For example, in chemically, virally, or spontaneously derived tumors, appreciable expression of HMGI-C was found in contrast with no detectableexpression in normal tissuesor untransformed cells (Giancotti et al., 1989) . A recent study has demonstrated a more direct role for HMGI-C in transformation (Berlingieri et al., 1995) . Cells infected with oncogenic retroviruses failed to exhibit various phenotypic markers of transformation if HMGI-C protein synthesis was specifically inhibited.
DNA probes adjacent to HMGI-C were mapped to mouse chromosome 10 in a region syntenic to the long arm of human chromosome 12, including and distal to band q13 (Justice et al., 1990) . This genomic region is under intensive investigation because it is the location of consistent rearrangements in a number of neoplasms, mainly of mesenchymal origin (Schoenberg Fejzo et al., 1995) . Lipomas, tumors mainly composed of mature fat cells, are one of the most common mesenchymal neoplasms that occur in humans (Sreekantaiah et al., 1991) . Approximately 50% of lipomas are characterized by cytogenetic rearrangements, and the predominant alteration is a presumably balanced translocation involving 12ql4-15 with a large variety of chromosomal partners, including 1, 2,3,4,5,6,7,10,11,13,15,17,21,andX (Sreekantaiahet al., 1991; Fletcheret al., 1993) . Thisvariability in reciprocal translocations, along with duplications, inversions, and deletions of 12q14-15 in these tumors, strongly indicates a primary role of a gene on chromosome 12 in lipomas. Furthermore, thisgene may play a key role in normal differentiation of primitive mesenchyme as not only lipomas, but also uterine leiomyomas(smooth muscle tumors), lipoleiomyomas (smooth muscle and adipose components), and pulmonary chondroid hamartomas (primitive mesenthyme, smooth muscle, adipose, and mature cartilage components) are all clonal proliferations that are characterized by rearrangements of 12q14-15 (Schoenberg Fejzo et al., 1995) . Interestingly, breakpoints in a lipoma, a pulmonary chondroid hamartoma and uterine leiomyomata, have been shown to map within a single yeast artificial chromosome (YAC) (Schoenberg Fejzo et al., 1995) .
HMGI-C is an attractive candidate gene to be implicated in lipoma formation. First, it is required in transformation (Berlingieri et al., 1995) and is a transcriptional regulatory factor, as are many genes identified at translocation breakpoints in a variety of tumors (Rabbitts, 1994) . Second, disruption of HMGI-C leads to mice of small stature that, most intriguingly, have disproportionately less body fat than normal littermates (Benson and Chada, 1994) . Finally, mouse HMGI-C maps to a region syntenic to human 12q14-15, which is the area most frequently rearranged in lipomas (Mandahl et al., 1988) . Therefore, the human homolog of the mouse HMGI-C gene was cloned and its possible role in lipomas investigated.
Results
Genomic Isolation and Characterization of the Human HMGI-C Gene To obtain genomic clones of HMGI-C, we subcloned DNA from yeast strains harboring YACs yWPR383 and yWPR384 into the LFIXII vector. Because there is extensive conservation (96%) between mouse and human HMGI-C homologs (Pate1 et al., 1994) , mouse HMGI-C cDNA fragments encompassing all five exons were used as probes on X libraries and five clones were isolated (Figure 1A) . Restriction mapping of li clones followed by Southern blot analysis allowed identification of various DNA fragments containing cross-hybridizing sequences. These fragments were subcloned and nucleotide sequence analysis confirmed published data (Pate1 et al., 1994) . The first three exons each contain a DNA-binding domain encoding the AT hook motif that is characteristic of the HMGI family (Reeves and Nissen, 1990) , and exons 4 and 5 encode the acidic domain of the molecule (Manfioletti et al., 1991) (Figure 1 B) . Notably, a large intron (>25 kb) between exons 3 and 4 separates the DNA-binding domains from the remainder of the protein ( Figure IB ).
Fluorescence
In Situ Hybridization of k HMGI-C Exon Clones to Lipoma Metaphase Chromosomes 1 clones from 5' and 3' ends of HMGI-C were used as probes for fluorescence in situ hybridization (FISH) to tumor metaphase chromosomes. In lipoma ST90-375, containing a t(12;15)(q15;q24) translocation, L clone H403, which contains the 5'end of the gene, gave a hybridization signal on the der(l2), thus mapping proximal to the breakpoint ( Figure 2A ). In contrast, X clone H4002, which contains a portion of the 3'end of the HMGI-C gene, gave a hybridization signal on the der(15) and therefore maps distal to the breakpoint (Figure 28 ). This result is consistent with a disruption of HMGI-C due to the t(12;15) in this lipoma. Two other lipomas with translocations in 12q15 were studied, similarly. In ST93724, containing a t(3; 12)(q29;q15), X clone H409 containing the 5' end of HMGI-C hybridized to the der(l2), while the 3' end clone H4002 hybridized to the der(3) ( Figures 2C and 2D ). In ST91-198, with a t(12;13)(ql4-22;q21-32), the 5' clone H403 mapped on the der(l3), suggesting a position distal to the breakpoint ( Figure 2E ). However, from the 3' end, no hybridization to either derivative chromosome was noted in 20 of 20 metaphases using k clone H4002, indicating that this portion of HMGI-C is deleted ( Figure 2F ). Therefore, in this tumor, the translocation appears to be proximal to HMGI-C, with the 5' end of the gene retained but the 3' end deleted, suggesting that the acidic tail of HMGI-C does not contribute to lipoma pathogenesis. Regardless of the chromosomal mechanisms involved in the translocations observed in lipomas, which may include a complex rearrangment in ST91-198, HMGI-C is disrupted in three out of three lipomas analyzed.
identification of Chimeric Transcripts The molecular structure of the HMGI-C transcripts in the lipomas was next investigated. Total RNA was isolated (Chirgwin et al., 1979) from primary cell cultures of ST90-375 t(l2;15) and 12) , and 3' rapid amplification of cDNA ends (RACE) performed (Frohman et al., 1988) . The resulting products were analyzed, and DNA fragments of size 441 and 627 bp were obtained from RNA samples isolated from STQO-375 and ST93-724, respectively ( Figure 3 ). These two DNA fragments were purified, subcloned, and sequenced. In both cases, sequence analysis revealed an in-frame fusion of novel sequences to HMGI-C. These sequences differed between the two lipomas and immediately followed exon 3 of HMGI-C (Figure 4) .
The presence and specificity of chimeric transcripts in the two lipomas were confirmed further by an independent reverse transcription polymerase chain reaction (RT-PCR). cDNA was prepared from lipoma RNA samples, but primers from the novel sequences, instead of oligo(dT), were used for the reverse transcription reaction so that only RNA transcripts spanning the translocation would result in a PCR amplification product ( Figure 5 ). Products of the predicted size were observed only when primers derived from the novel sequences were used to reverse transcribe RNA isolated from the corresponding cell lines. The normal chromosome 12 homologs provide internal positive hybridization controls and are marked by yellow arrows in each metaphase, while derivative chromosomes are marked by red arrows. h clones H403 and H409 from the 5' end of HMGI-C were used as FISH probes to lipoma metaphase chromosomes from ST90-375 (A) and ST93-724 (C), respectively. Note hybridization on the normal chromosome 12 and the der(l2), demonstrating that these clones map proximal to the breakpoint in both lipomas. In contrast, when H403 was hybridized to lipoma metaphase chromosomes from ST91-198 (E), hybridization was observed on the der (13) showing a map position distal to the breakpoint in this tumor. H4002 from the 3' end of HMGI-C was used as a FISH probe to lipoma metaphase chromosomes from ST90-375(B)and ST93-724(D); note hybridization on the normal chromosome 12 and the der(15) or der(3), respectively, indicating that these clones map distal to the breakpoint in both lipomas. However, FISH with H4002 from the B'end of HMGI-C on ST91-196 (F) revealed hybridization on the normal chromosome 12 only, suggesting this clone is deleted from either the der(12) or der (13) No products were seen in lipoma RNA from STQO-375 or ST93-724 when primers 724 or 375 were used, respectively. Finally, the chromosomal origin of the novel sequences was determined using DNA prepared from a mono chromosomal rodent-human somatic cell hybrid panel. Specific primers were designed for the two novel sequences obtained from the lipoma cDNAs. PCR performed on genomic DNA from the somatic cell hybrids demonstrated that the novel sequence fused to HMGI-C in ST93-724, with a t(3;12), was located on chromosome 3 and the novel sequence from STQO-375, with a t(l2; 15) mapped to chromosome 15 (data not shown).
Novel Sequences
Encode for Transcriptional Regulatory Domains A detailed computer analysis of the novel sequences from the two amplified fusion transcripts demonstrated that they encode putative transcriptional regulatory domains. In- (724) yield 441 bp and 672 bp products, respectively. Reverse transcription was performed with an oligo(dT) primer linked to an adapter sequence and was followed by a nested PCR with sense primers from exon 1 and spanning exons 1 and 2. DLD-1 is a colorectal adenocarcinoma cell line that expresses wild-type HMGI-C (data not shown), but under these conditions, the predicted 3.1 kb wild-type message was not amplified. Products were analyzed on a 1.5% agarose gel. Lane M shows molecular size markers in kilobases.
spection of the predicted protein sequence from ST93-724 revealed the presence of two tandemly arrayed LIM domains (Sanchez-Garcia and Rabbitts, 1993) separated by the characteristic 8-10 amino acids ( Figure 8A ). These domains are 50-80 amino acid residue motifs that are rich in cysteine and histidine and were first identified in three proteins, LIN-11, Isl-l , and MECB (Way and Chalfie, 1988; Freyd et al., 1990; Karlsson et al., 1990 ). The domain is organized into two adjacent zinc fingers separated by a two residue linker (Feuerstein et al., 1994) , and members of the LIM family of proteins may contain one or more LIM domains (Sanchez-Garcia et al., 1993) . Many of the LIM-containing proteins are transcription factors (SdnchezQarcfa et al., 1993) and their activity is thought to be regulated by protein-protein interactions through the ability of LIM domains to dimerize (Feuerstein et al., 1994) .
Computer analysis of the novel sequence from ST90-375 did not reveal any significant homology with known sequences. Notably, the carboxy-terminal end of the predicted protein is highly acidic (pl 4.8) and rich in serine and threonine residues (Figure 88 ). Such domains have been implicated in transcriptional activation and have been shown to stimulate transcription from remote as well as proximal positions (Mitchell and Tijan, 1989; Seipel et al., 1992) .
Therefore, the predicted domain organization of the wild-type HMGI-C and the fusion proteins can be schematically depicted as shown in Figure 7 . In both fusion proteins, the C-terminal domain of the wild-type HMGI-C, which does not activate transcription (Thanos and Maniatis, 1992; X. Z. and K. C., unpublished data), is replaced by distinct, potential transcription regulation domains. These newly acquired functional domains in combination with the AT hooksof HMGI-C would give rise to unique proteins that may contribute to the pathobiology of lipomas. 
Discussion
In this study, chimeric transcripts were identified from two lipomas that resulted from fusion of the 5' end of the HMGI-C gene to novel sequences derived from different chromosomes.
Three DNA-binding domains containing the AT hook motifs of HMGI-C are linked in these transcripts to sequences encoding potential transcriptional regulatory domains. In the case of lipoma ST99-375, the novel domain is highly acidic and rich in serine and threonine residues, resembling the typical activation domains found in transcription factors. In lipoma ST93-724, the novel protein contains two LIM domains, motifs that promote protein-protein interactions.
HMGI-C, Chimeric Transcripts, and Lipomas The chromosomal region 12q14-15 is hypothesized to contain an important gene involved in lipomas because it is the most commonly rearranged site (Mandahl et al., 1988) . Our study establishes that HMGI-C is the gene disrupted in lipomas with chromosome 12 rearrangements.
The large intron (>25 kb) between exons 3 and 4 distinctly separates the DNA binding from the acidic domains of HMGI-C. This provides a substantial target for translocations so that the three AT hook motifs remain intact and confer the DNA binding specificity of HMGI-C to the fusion proteins.
HMGI-C is a 109 amino acid residue protein (Pate1 et al., 1994) that consists of three DNA-binding domains (AT hooks) linked to the carboxy-terminal acidic domain that does not activate transcription (Thanos and Maniatis, 1992; X. Z. and K. C., unpublished data). The two lipoma translocations result in a novel protein containing AT hooksof HMGI-C at the amino terminus fused to transcrip- tional regulatory domains at the carboxyl end. The other reported example for an AT hook-containing gene implicated in tumorigenesis is MLL (Tkachuk et al., 1992; Gu et al., 1992) . However, the presence of a putative second DNA-binding domain (Ma et al., 1993) derived from the MLL gene and retained in the fusion protein obscures the exact contribution of the AT hooks to tumor pathogenesis (Rabbitts, 1994) . In these lipomas, theonly known HMGI-C functional domains retained in the fusion proteins are the AT hooks. These motifs would therefore be responsible for DNA binding specificity of the fusion proteins. Although it is possible that simple truncation of HMGI-C is sufficient to cause lipomas, a number of studies have determined that both domains of fusion proteins are necessary for transforming activity (de Th6 et al., 1991; Kamps et al., 1991; Pendergast efal., 1991; Mayetal., 1993) .Therefore, as proposed for other fusion proteins, the heterologous sequence in the lipoma fusion proteins would alter the biological activity of wild-type HMGI-C and lead to deregulation of downstream target genes.
The above model readily explains how the fusion protein produced in lipoma ST90-375 may function. The novel sequence from chromosome 15 encodes for an acidic pep tide rich in serine and threonine residues. These features have been observed in a number of transcriptional activation domains (Mitchell and Tijan, 1989) , including the carboxy-terminal domains of homeobox proteins (Hatano et al., 1991) and NF-~B (Schmitzand Baeuerle, 1991) . Sothe acquisition of a transactivation domain by the DNA-binding domains of HMGI-C, which normally possesses a transcriptionally inactive acidic domain, can easily be reconciled with aberrant regulation of the HMGI-C target genes. are shown in bold. The amino acid spacing between residues is indicated by an x. In addition to the totally conserved cysteine, histidine, and aspartic acid residues (Sadler et al., 1992) , LIM domains are characterized by the presence of an aromatic residue adjacent to the first histidine and a leucine located carboxy-terminal to the central HxxCxxCxxC cluster, which are indicated by arrows. Each LIM domain is designated 1, 2, or 3 depending on its position relative to the amino terminus. (B) The potential transactivation acidic domain encoded by the sequence derived from chromosome 15 in ST90-375. Acidic residues are underlined and the amino acids serine and threonine are in bold.
In the case of the t(3;12) in ST93-724, the fusion protein must operate by a different mechanism to deregulate the HMGI-C target genes. The novel sequence from chromosome 3 encodes for two tandemly arranged LIM motifs. The LIM domain is conserved among highly diverged spe- ties, and LIM proteins have been shown to have important developmental functions that include patterning (Cohen et al., 1992) cell fate decision (Freyd et al., 1990) , and differentiation (Way and Chalfie, 1988) . LIM domain proteins are capable of protein-protein interactions (Sadler et al., 1992) through dimerization mediated by the LIM domains (Feuerstein et al., 1994) . Therefore, LIM-LIM interactions between the ST93724 fusion product and other nuclear proteins could recruit potential transcriptional regulators to DNA sequences with a specificity dictated by the HMGI-C AT hook motifs. Deregulation of HMGI-C target genes would then contribute to lipoma development. It is interesting to note that the majority of nuclear proteins capable of interacting with LIM domains are known to function as transcription factors. These include several LIM homeodomain proteins (Sanchez-Garcia et al., 1993 and references within) as well as basic helix-loop-helix proteins shPan-1 (German et al., 1992) and TALl (Valge-Archer et al., 1994) . While overexpression of LIM proteins has been implicated in T cell lymphomas (reviewed by SanchezGarcfa and Rabbit&, 1993) here we have an example of a LIM domain occurring in a fusion product.
A great heterogeneity in chromosomal partners translocated with 12q14-15 is found in karyotypicalty abnormal lipomas, indicating that a large number of sequences in the genome can be fused to HMGI-C. Our data demonstrate that novel sequences linked to HMGI-C in two lipomas encode for distinct domains. This suggests that a number of alternative domains can be placed downstream of the HMGI-C AT hooks and contribute to the pathobiology of lipomas. Interestingly, both novel sequences described in this study encode for transcriptional regulatory domains. Therefore, we speculate that the choice of novel sequences in chimeric transcripts in lipomas is not arbitrary but does require the presence of regulatory transcriptional domains attached to the HMGI-C AT hooks. A similar situation has been observed in the 11 q23 acute leukemia% where the MLL gene is translocated with multiple chromosomal partners that mostly encode different types of transcriptional regulatory domains (Prasad et al., 1994) . This could be a general mechanism for tumors where nonrandom rearrangements of a specific chromosomal region involve avarietyof partners. Chimeric transcription factors that promote tumorigenesis would be produced by juxtaposing DNA-binding domain(s) contributed by the consistently rearranged locus to distinct types of transcriptional regulatory domains.
HMGI-C, Pygmy, and Adipogcnesis
The above studies demonstrate that an altered HMGI-C protein is involved in the abnormal growth and development of fat cells resulting in lipomas. This leads to the possibility that HMGI-C may normally play a role in adipogenesis, and analysis of the pygmy mouse strongly substantiates this hypothesis. The mouse mutant pygmy was found to be a null mutation of HMGI-C due to deletions within the gene (Zhou et al., submitted) . The obvious phenotypic characteristic of the pygmy mouse is its small size, and the reduction in most tissues is commensurate with the overall decrease in weight of the mouse (40% of wild type). Interestingly, one tissue disproportionately reduced in weight is body fat. The fat index, a reliable indicator of total fat content relative to body weight (Rogers and Webb, 1980 ) is approximately eight times lower in pygmy than in their wild-type littermates (Benson and Chada, 1994) . The function of HMGI-C in adipogenesis could be related to its role in cells undergoing differentiation. It isexpressed in less differentiated cells, but no detectable levels are observed in their terminally differentiated counterparts (Vartainen et al., 1988; Giancotti et al., 1987) . Therefore, lack of HMGI-C expression, as found in the pygmy mouse, could affect the differentiation of preadipocytes into mature adipocytes, cells capable of lipid storage. This developmental abnormality would lead to adecrease in fat deposition and the phenotype observed in the pygmy mouse. The role of HMGI-C in adipogenesis and metabolic disorders such as obesity is thus of considerable interest.
HMGI Family in Benign Tumors of Mesenchymal
Origin Of major importance is the frequent observation of chromosomal rearrangements in bands 12ql3-15 in a large group of benign solid tumors. Most prominently, these include uterine leiomyomata (Nilbert and Heim, 1990) and pleomorphic adenomas of the salivary gland (Sandros et al., 1990) . Rearrangements of 12q13-15 have also been reported in pulmonary chondroid hamartomas (Dal Cin et al., 1993) endometrial polyps (Vanni et al., 1993) , epithelial breast tumors (Rohen et al., 1993) , hemangiopericytoma (Mandahl et al., 1993) chondromatous tumors (Mandahl et al., 1989 ) diffuse astrocytomas (Jenkins et al., 1989) parosteal lipoma (Bridge et al., 1995) , and a giant cell tumor of the bone (Noguera et al., 1989) . Many of these tumor types are of mesenchymal origin, and it has therefore been hypothesized that a single gene associated with growth and mesenchyme may be responsible for these multiple neoplasms (Schoenberg Fejzo et al., 1995) . Several lines of evidence implicate HMGI-C as a strong candidate for such a gene at 12q14-15. First, physical mapping studies have shown chromosomal breakpoints for three of these benign tumors (lipoma, pulmonary chondroid hamartoma, and uterine leiomyoma) to map within a single YAC (Schoenberg Fejzo et al., 1995) . This study assigns HMGI-C to the translocation breakpoint in lipomas, and chromosomal breakpoints in five analyzed uterine leiomyomata, as well as in a pulmonary chondroid hamartoma, have been found to reside within lo-100 kb of exon 1 of HMGI-C (M. S. F. et al., unpublished data) . Second, the role of HMGI-C in growth control is apparent because its disruption in the pygmy mouse leads to aberrant growth and development. Also, it has been shown in vitro that HMGI-C is required fortransformation (Berlingieri et al., 1995) . Finally, preliminary studies reveal that expression of HMGI-C during mouse embryogenesis is restricted mainly to the mesenchymal component of tissues and organs (K. Benson, Y. Hou, and K. C., unpublished data) . Taken together, these data indicate that HMGI-C is highly likely to be the gene disturbed by 12q14-15 rearrangements in a number of tumors of mesenchymal origin.
Intriguingly, lipomas and the heterogeneous group of other mesenchymal neoplasms are benign tumors that rarely, if ever, undergo malignant conversion (Nilbert and Heim, 1990; Sandros et al., 1990; Sreekantaiah et al., 1991) . Molecular analyses of these neoplasms may elucidate factors of decisive importance that minimize the likelihood of malignant progression. Although speculative at this stage, certain functional properties of HMGI-C suggest this molecule as a candidate for such a factor in the stabilization of the benign tumor state. For example, as an architectural factor important for the organization of higher order chromatin structures (Saitoh and Laemmli, 1994) , HMGI-C may play a role in the maintenance of genomic stability, thus preventing or retarding conversion of benign tumors to malignant ones. Interestingly, lipomas and other benign mesenchymal tumors that are likely to involve HMGI-C are characterized generally by few cytogenetic rearrangements as compared with the highlycomplex karyotypes typical of malignant tumors with a high degree of genomic instability (Fletcher et al., 1990 ). An equally valid hypothesis is the function of HMGI-C as an accessory transcription factor that may activate expression of tumor suppressor genes, inhibit transcription of genes involved in malignant transformation (Yuspa et al., 1969) , or both. In any case, the molecular analysis of hyperproliferating adipocytes in lipomas and mesenchymally derived cells in other benign tumors will provide insight into multiple independent events that cooperate to initiate and promote benign tumorigenesis.
Nonrandom involvement of 6~21-23 has also been observed in lipomas (Sreekantaiah et al., 1991) , pulmonary chondroid hamartomas (Fletcher et al., 1992) and uterine leiomyomata (Nilbert and Heim, 1990) . Interestingly, HMGI(Y), the other member of the HMGI protein family with a similar structure as HMGI-C that includes the three DNA-binding domains, has been localized to 6~21 (Friedmann et al., 1993) . This raises an intriguing possibility that HMGI(Y), a molecule closely related to, but distinct from HMGI-C, could also be associated with benign tumors of mesenchymal origin.
We show that a disruption of the HMGI-C gene resulting in chimeric transcripts is a characteristic feature of lipomas. As adipocytes play a key role in lipid homeostasis and maintenance of energy balance in vertebrates, an understanding of HMGI-C function in adipogenesis may lead to insights into obesity and other metabolic disorders. In addition, the obvious role of HMGI-C in normal growth demonstrated by the phenotype of the pygmy mouse and its localization at or adjacent to the translocation breakpoints in lipoma, uterine leiomyoma, and pulmonary chondroid hamartoma suggests its fundamental involvement in a variety of benign tumors.
Experimental Procedures isolation of YACs at the Human Pygmy Locus Initially, conserved fragments ware isolated from DNA at the mouse pygmy locus (Xiang et al., 1990 ; K. Benson and K. C., unpublished data) and were used as probes on a normal human I genomic library (Sambrook et al., 1989 and yWPR384 (Guthrie and Fink, 1991) and was partially digested with Sau3A. After partial fill in of the Sau3A site, DNA was subcloned at the partially filled Xhol site of the predigested lFlXll vector (Stratagene, La Jolla, CA) and packaged in vitro (GIGA-PACK II packaging extract; Stratagene).
To select clones derived from the human YACs, 6066 plaques from each library were probed with total human genomic DNA, and hybridizing plaques were spotted on plates inoculated with SRB(PP) cells in a gridded array. After incubating the plates at 3Q°C for 12 hr, plaques were transferred onto DURALON (Stratagene) membranes. These grids were used for identifying I clones that contained human HMGI-C exons by probing with mouse HMGI-C cDNA (Zhou et al., submitted), using hybridization conditions as described for Southern blot analysis (D'Armiento et al., 1992) (Rother, 1992) using the following conditions: 94% for 30 s, 56OC for 20 s, 72OC for 1.5 min. Antisense primer (10 pmol) was then added, and 25 cycles of exponential amplification were performed (94% for 30 s, 56% for 30 s, 72% for 1.5 min). PCR (1 pl) was reamplified for 20 cycles with a nested HMGI-C sense primer spanning exons 1 and 2,5'-GGAAGCAGCAGCAAGAACC, as described above. Each reaction (5 pl) was analyzed on a 1.5% agarose gel. Reverse transcription for the detection of chimeric transcripts using novel sequence-specific primers was performed as above, except primers 375 (S-CTTCTITCTCTGCCGCATCG) for STQO-375 and 724 (5'-GTGAG-GATGATAGGCCTTCC) for ST93-724 were used. Subsequent PCR conditions were an initial denaturation at 94OC for 2 min and 30 cycles at 94°C for 30 s, 58% for 30 s, and 72OC for 1 min, followed by a final extension for 10 min at 72°C.
Chimeric transcripts amplified by 3' RACE and RT-PCR were isolated from the gel, blunt-end cloned by standard methods (Sambrook et al., 1989) into the pCR-Script vector (Stratagene). and sequenced using the Sequenase kit version 2.0 (United States Biochemicals, Cleveland, OH).
Tumor Cell Lines and Chromosome Preparations Lipoma specimens were obtained from patients at the time of surgery. Tumor culture, metaphase chromosome harvesting, slide preparation, and trypsin-Giemsa banding were performed as described previously (Fletcher et al., 1991) . Metaphases with rearrangements of chromosome 12 in band q15 were identified, and corresponding cell pellets were stored in fixative at -20% were used to prepare slides for FISH. These slides were stored at room temperature for at least 10 days prior to hybridization.
1 clones shown in Figure 1 FISH with I Clones Slides for FISH were prepared as recommended in the hybridization kit by Onwr (Gaithersburg, MD) except for denaturation at 88% for 30 s. 5 probes were labeled with digoxigenin-11 dUTP (Boehringer Mannheim, Indianapolis, IN) using 1 pg of the appropriate 1, DNA using dNTPs obtained from Boehringer Mannheim and the DNase I-DNA polymerase I mix from the BioNick labeling system (Bethesda Reasearch Laboratories).
Labeling reactions were performed at 18°C for 2 hr. Digoxigenin-labeled probe (500 ng) was lyophilized with 5 pg of Cot-l DNA (Bethesda Research Laboratories) and resuspended in 20 ~1 deionized water. Resuspended probe (2 ~1) was added to 9 PI of Hybrisol VI (Oncor). The 5 probe was denatured, hybridized to slides, and washed according to standard protocols (Oncor). Digoxigeninlabeled 5 clones were detected using the fluorescein-labeled antidigoxigenin antibody (Oncor) according to the recommendations of the manufacturer.
Metaphase chromosomes were counterstained with 4,8diamidino-2-phenylindole-dihydrochloride (DAPI) according to the protocol supplied by Oncor. Hybridization was observed using a Zeiss Axioskop microscope and images captured with the CytoVision Imaging System (Applied Imaging).
